AAAAAA
Results: 1-25/29
Authors:
Simpson, JF
Page, DL
Edgerton, ME
Citation: Jf. Simpson et al., p53 in mammary ductal carcinoma in situ, mutations in high-grade lesions only?, J NAT CANC, 93(9), 2001, pp. 666-667
Authors:
Simpson, JF
Page, DL
Citation: Jf. Simpson et Dl. Page, Pathology of preinvasive and excellent prognosis breast cancer, CURR OPIN O, 13(6), 2001, pp. 426-430
Authors:
Page, DL
Simpson, JF
Citation: Dl. Page et Jf. Simpson, What is apocrine adenosis, anyway?, HISTOPATHOL, 39(4), 2001, pp. 433-433
Authors:
Ely, KA
Carter, BA
Jensen, RA
Simpson, JF
Page, DL
Citation: Ka. Ely et al., Core biopsy of the breast with atypical ductal hyperplasia - A probabilistic approach to reporting, AM J SURG P, 25(8), 2001, pp. 1017-1021
Authors:
Gobbi, H
Jensen, RA
Simpson, JF
Olson, SJ
Page, DL
Citation: H. Gobbi et al., Atypical ductal hyperplasia and ductal carcinoma in situ of the breast associated with perineural invasion, HUMAN PATH, 32(8), 2001, pp. 785-790
Authors:
Carter, BA
Page, DL
Schuyler, P
Parl, FF
Simpson, JF
Jensen, RA
Dupont, WD
Citation: Ba. Carter et al., No elevation in long-term breast carcinoma risk for women with fibroadenomas that contain atypical hyperplasia, CANCER, 92(1), 2001, pp. 30-36
Authors:
Carter, BA
Jensen, RA
Simpson, JF
Page, DL
Citation: Ba. Carter et al., Another variable in lymph node biopsy - The author's reply, AM J CLIN P, 114(2), 2000, pp. 294-295
Authors:
Ely, KA
Tse, G
Simpson, JF
Clarfeld, R
Page, DL
Citation: Ka. Ely et al., Diabetic mastopathy - A clinicopathologic review, AM J CLIN P, 113(4), 2000, pp. 541-545
Authors:
Carter, BA
Jensen, RA
Simpson, JF
Page, DL
Citation: Ba. Carter et al., Benign transport of breast epithelium into axillary lymph nodes after biopsy, AM J CLIN P, 113(2), 2000, pp. 259-265
Authors:
Gobbi, H
Tse, G
Page, DL
Olson, SJ
Jensen, RA
Simpson, JF
Citation: H. Gobbi et al., Reactive spindle cell nodules of the breast after core biopsy or fine-needle aspiration, AM J CLIN P, 113(2), 2000, pp. 288-294
Authors:
Page, DL
Jensen, RA
Simpson, JF
Dupont, WD
Citation: Dl. Page et al., Historical and epidemiologic background of human premalignant breast disease, J MAMMARY G, 5(4), 2000, pp. 341-349
Authors:
Page, DL
Simpson, JF
Citation: Dl. Page et Jf. Simpson, Pathology of preinvasive and excellent-prognosis breast cancer, CURR OPIN O, 12(6), 2000, pp. 526-531
Authors:
Kasami, M
Gobbi, H
Dupont, WD
Simpson, JF
Page, DL
Vnencak-Jones, CL
Citation: M. Kasami et al., Androgen receptor CAG repeat lengths in ductal carcinoma in situ of breast, longest in apocrine variety, BREAST, 9(1), 2000, pp. 23-27
Authors:
Simpson, JF
Gray, R
Dressler, LG
Cobau, CD
Falkson, CI
Gilchrist, KW
Pandya, KJ
Page, DL
Robert, NJ
Citation: Jf. Simpson et al., Prognostic value of histologic grade and proliferative activity in axillary node-positive breast cancer: Results from the Eastern Cooperative Oncology Group companion study, EST 4189, J CL ONCOL, 18(10), 2000, pp. 2059-2069
Authors:
Mizobata, S
Tompkins, K
Simpson, JF
Shyr, Y
Primus, FJ
Citation: S. Mizobata et al., Induction of cytotoxic T cells and their antitumor activity in mice transgenic for carcinoembryonic antigen, CANCER IMMU, 49(6), 2000, pp. 285-295
Authors:
Gobbi, H
Arteaga, CL
Jensen, RA
Simpson, JF
Dupont, WD
Olson, SJ
Schuyler, PA
Plummer, WD
Page, DL
Citation: H. Gobbi et al., Loss of expression of transforming growth factor beta type II receptor correlates with high tumour grade in human breast in-situ and invasive carcinomas, HISTOPATHOL, 36(2), 2000, pp. 168-177
Authors:
Lenferink, AEG
Simpson, JF
Shawver, LK
Coffey, RJ
Forbes, JT
Arteaga, CL
Citation: Aeg. Lenferink et al., Blockade of the epidermal growth factor receptor tyrosine kinase suppresses tumorigenesis in MMTV/Neu plus MMTV/TGF-alpha bigenic mice, P NAS US, 97(17), 2000, pp. 9609-9614
Authors:
Kurokawa, H
Lenferink, AEG
Simpson, JF
Pisacane, PI
Sliwkowski, MX
Forbes, JT
Arteaga, CL
Citation: H. Kurokawa et al., Inhibition of HER2/neu (erbB-2) and mitogen-activated protein kinases enhances tamoxifen action against HER2-ovorexpresessed tamoxifen-resistant breast cancer cells, CANCER RES, 60(20), 2000, pp. 5887-5894
Authors:
Simpson, JF
Page, DL
Citation: Jf. Simpson et Dl. Page, The p53 tumor suppressor gene in ductal carcinoma in situ of the breast, AM J PATH, 156(1), 2000, pp. 5-6
Authors:
Gobbi, H
Dupont, WD
Simpson, JF
Plummer, WD
Schuyler, PA
Olson, SJ
Arteaga, CL
Page, DL
Citation: H. Gobbi et al., Transforming growth factor-beta and breast cancer risk in women with mammary epithelial hyperplasia, J NAT CANC, 91(24), 1999, pp. 2096-2101
Authors:
Riera, J
Simpson, JF
Tamayo, R
Battifora, H
Citation: J. Riera et al., Use of cultured cells as a control for quantitative immunocytochemical analysis of estrogen receptor in breast cancer - The Quicgel method, AM J CLIN P, 111(3), 1999, pp. 329-335
Authors:
Gobbi, H
Atkinson, JB
Kardos, TF
Simpson, JF
Page, DL
Citation: H. Gobbi et al., Inflammatory myofibroblastic tumour of the breast: report of a case with giant vacuolated cells, BREAST, 8(3), 1999, pp. 135-138
Authors:
McGonigle, KF
Vasilev, SA
Odom-Maryon, T
Simpson, JF
Citation: Kf. Mcgonigle et al., Ovarian histopathology in breast cancer patients receiving tamoxifen, GYNECOL ONC, 73(3), 1999, pp. 402-406
Authors:
Gobbi, H
Simpson, JF
Jensen, RA
Coogan, AC
Page, DL
Citation: H. Gobbi et al., Prostatic adenocarcinoma with glomeruloid features, HUMAN PATH, 30(1), 1999, pp. 111-112
Authors:
Page, DL
Simpson, JF
Citation: Dl. Page et Jf. Simpson, Ductal carcinoma in situ - The focus for prevention, screening, and breastconservation in breast cancer, N ENG J MED, 340(19), 1999, pp. 1499-1500